Literature DB >> 26412079

SLUG and SOX9 Cooperatively Regulate Tumor Initiating Niche Factors in Breast Cancer.

Hassan Fazilaty1,2,3, Mossa Gardaneh4, Parvin Akbari4, Ali Zekri2, Babak Behnam5,6.   

Abstract

Presence of tumor initiating cells and a proper niche is essential for metastatic colonization. SLUG and SOX9 transcription factors play essential roles in induction and maintenance of tumor initiating capacity in breast cancer cells. On the other hand, Tenascin-C and Periostin are crucial factors in metastatic niche that support tumor initiating capability in breast cancer. In this study, regulatory effect of SLUG and SOX9 transcription factors on the expression of Tenascin-C and Periostin was examined. SLUG and SOX9 were overexpressed and knocked-down in MCF7 and MDA-MB-231 cells, respectively. The cells as little and highly invasive breast cancer-derived cells were infected by inducing and shRNA lentivirus constructs. Then, Tenascin-C and Periostin as well as SLUG and SOX9 expression levels were measured in the cells via Real-Time PCR. Simultaneous overexpression of SLUG and SOX9 significantly induced Tenascin-C and Periostin expression. SLUG and SOX9 knock-down also significantly reduced the expression of Tenascin-C and Periostin. In this analysis Periostin showed the most deviation in both up- and down-regulation levels. This regulatory effect might shed light to a crosstalk between factors involved in the tumor initiating capacity and metastatic niche of the breast cancer.

Entities:  

Keywords:  Breast cancer stem cell; Persiostin; Slug; Sox9; Tenascin-C

Year:  2015        PMID: 26412079      PMCID: PMC4842180          DOI: 10.1007/s12307-015-0176-8

Source DB:  PubMed          Journal:  Cancer Microenviron        ISSN: 1875-2284


  14 in total

Review 1.  Tumor metastasis: molecular insights and evolving paradigms.

Authors:  Scott Valastyan; Robert A Weinberg
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

Review 2.  Epithelial plasticity: a common theme in embryonic and cancer cells.

Authors:  M Angela Nieto
Journal:  Science       Date:  2013-11-08       Impact factor: 47.728

3.  Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast.

Authors:  Christina Scheel; Elinor Ng Eaton; Sophia Hsin-Jung Li; Christine L Chaffer; Ferenc Reinhardt; Kong-Jie Kah; George Bell; Wenjun Guo; Jeffrey Rubin; Andrea L Richardson; Robert A Weinberg
Journal:  Cell       Date:  2011-06-10       Impact factor: 41.582

4.  Synergy between glutathione peroxidase-1 and astrocytic growth factors suppresses free radical generation and protects dopaminergic neurons against 6-hydroxydopamine.

Authors:  Mossa Gardaneh; Mostafa Gholami; Nader Maghsoudi
Journal:  Rejuvenation Res       Date:  2011-01-11       Impact factor: 4.663

5.  Interactions between cancer stem cells and their niche govern metastatic colonization.

Authors:  Ilaria Malanchi; Albert Santamaria-Martínez; Evelyn Susanto; Hong Peng; Hans-Anton Lehr; Jean-Francois Delaloye; Joerg Huelsken
Journal:  Nature       Date:  2011-12-07       Impact factor: 49.962

6.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

Review 7.  Crosstalk between breast cancer stem cells and metastatic niche: emerging molecular metastasis pathway?

Authors:  Hassan Fazilaty; Mossa Gardaneh; Tayyeb Bahrami; Arash Salmaninejad; Babak Behnam
Journal:  Tumour Biol       Date:  2013-05-19

8.  Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3.

Authors:  Damian Medici; Elizabeth D Hay; Bjorn R Olsen
Journal:  Mol Biol Cell       Date:  2008-09-17       Impact factor: 4.138

Review 9.  Genetics of breast cancer bone metastasis: a sequential multistep pattern.

Authors:  Hassan Fazilaty; Parvin Mehdipour
Journal:  Clin Exp Metastasis       Date:  2014-02-04       Impact factor: 5.150

10.  The perivascular niche regulates breast tumour dormancy.

Authors:  Cyrus M Ghajar; Héctor Peinado; Hidetoshi Mori; Irina R Matei; Kimberley J Evason; Hélène Brazier; Dena Almeida; Antonius Koller; Katherine A Hajjar; Didier Y R Stainier; Emily I Chen; David Lyden; Mina J Bissell
Journal:  Nat Cell Biol       Date:  2013-06-02       Impact factor: 28.824

View more
  10 in total

1.  Positive selection of the TRIM family regulatory region in primate genomes.

Authors:  Dan-Dan He; Yueer Lu; Rachel Gittelman; Yabin Jin; Fei Ling; Akey Joshua
Journal:  Proc Biol Sci       Date:  2016-10-12       Impact factor: 5.349

2.  CD271 Confers an Invasive and Metastatic Phenotype of Head and Neck Squamous Cell Carcinoma through the Upregulation of Slug.

Authors:  Man Ki Chung; Young Ho Jung; Joon Kyoo Lee; Soo Youn Cho; Oihana Murillo-Sauca; Ravindra Uppaluri; June Ho Shin; John B Sunwoo
Journal:  Clin Cancer Res       Date:  2017-12-05       Impact factor: 12.531

3.  Long non-coding RNA GAS6-AS1 enhances breast cancer cell aggressiveness by functioning as a competing endogenous RNA of microRNA-215-5p to enhance SOX9 expression.

Authors:  Xiu-Ping Wu; Zhi-Qiang Xu; Wang-Mei Xie; Yao-Long Lai; Kai He; Yan Jiang; Zhen-Chao Xu; Yi-Na Lin; Yuan-Fu Xie
Journal:  Exp Ther Med       Date:  2021-12-02       Impact factor: 2.447

Review 4.  SOX9: The master regulator of cell fate in breast cancer.

Authors:  Samir Jana; B Madhu Krishna; Jyotsana Singhal; David Horne; Sanjay Awasthi; Ravi Salgia; Sharad S Singhal
Journal:  Biochem Pharmacol       Date:  2020-01-03       Impact factor: 6.100

5.  Cytoplasmic expression of SOX9 as a poor prognostic factor for oral squamous cell carcinoma.

Authors:  Yoshimasa Sumita; Manabu Yamazaki; Satoshi Maruyama; Tatsuya Abé; Jun Cheng; Ritsuo Takagi; Jun-Ichi Tanuma
Journal:  Oncol Rep       Date:  2018-08-22       Impact factor: 3.906

6.  LncRNA-mediated regulation of SOX9 expression in basal subtype breast cancer cells.

Authors:  Aamira Tariq; Qinyu Hao; Qinyu Sun; Deepak K Singh; Mahdieh Jadaliha; Yang Zhang; Neha Chetlangia; Jian Ma; Sarah E Holton; Rohit Bhargava; Ashish Lal; Supriya G Prasanth; Kannanganattu V Prasanth
Journal:  RNA       Date:  2019-11-05       Impact factor: 4.942

7.  Clinicopathological and prognostic significance of SOX9 expression in gastric cancer patients: A meta-analysis.

Authors:  Qian Wang; Hao Chen; Congying Yang; Yi Liu; Feng Li; Chunfang Zhang
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

8.  Utilizing an Endogenous Progesterone Receptor Reporter Gene for Drug Screening and Mechanistic Study in Endometrial Cancer.

Authors:  Yiyang Li; Wei Zhou; Xiangbing Meng; Sarina D Murray; Long Li; Abby Fronk; Vanessa J Lazaro-Camp; Kuo-Kuang Wen; Meng Wu; Adam Dupuy; Kimberly K Leslie; Shujie Yang
Journal:  Cancers (Basel)       Date:  2022-10-06       Impact factor: 6.575

9.  Stratification and therapeutic potential of PML in metastatic breast cancer.

Authors:  Natalia Martín-Martín; Marco Piva; Jelena Urosevic; Paula Aldaz; James D Sutherland; Sonia Fernández-Ruiz; Leire Arreal; Verónica Torrano; Ana R Cortazar; Evarist Planet; Marc Guiu; Nina Radosevic-Robin; Stephane Garcia; Iratxe Macías; Fernando Salvador; Giacomo Domenici; Oscar M Rueda; Amaia Zabala-Letona; Amaia Arruabarrena-Aristorena; Patricia Zúñiga-García; Alfredo Caro-Maldonado; Lorea Valcárcel-Jiménez; Pilar Sánchez-Mosquera; Marta Varela-Rey; Maria Luz Martínez-Chantar; Juan Anguita; Yasir H Ibrahim; Maurizio Scaltriti; Charles H Lawrie; Ana M Aransay; Juan L Iovanna; Jose Baselga; Carlos Caldas; Rosa Barrio; Violeta Serra; Maria dM Vivanco; Ander Matheu; Roger R Gomis; Arkaitz Carracedo
Journal:  Nat Commun       Date:  2016-08-24       Impact factor: 14.919

Review 10.  SOX9 Stem-Cell Factor: Clinical and Functional Relevance in Cancer.

Authors:  Maribel Aguilar-Medina; Mariana Avendaño-Félix; Erik Lizárraga-Verdugo; Mercedes Bermúdez; José Geovanni Romero-Quintana; Rosalío Ramos-Payan; Erika Ruíz-García; César López-Camarillo
Journal:  J Oncol       Date:  2019-04-01       Impact factor: 4.375

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.